Compounds for enzyme inhibition

Details for Australian Patent Application No. 2012201520 (hide)

Owner Proteolix, Inc.

Inventors Smyth, Mark S.; Laidig, Guy J.; Borchardt, Ronald T.; Bunin, Barry A.; Crews, Craig M.; Musser, John H.; Shenk, Kevin D.; Radel, Peggy A.

Agent Shelston IP

Pub. Number AU-A-2012201520

Parent 2005243168

Filing date 14 March 2012

Wipo publication date 5 April 2012

International Classifications

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

C07D 303/32 (2006.01) Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07K 5/027 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/062 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/078 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

29 March 2012 Complete Application Filed

5 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201520

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201521-Modified clostridial toxins with enhanced targeting capabilites for endogenous clostridial toxin receptor systems

2012201519-Animal product free system and process for purifying a botulinum toxin